查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1832513

细胞分离技术市场（按技术、产品、细胞类型、分离模式、应用和最终用户划分）—全球预测 2025-2032

Cell Separation Technologies Market by Technology, Product, Cell Type, Separation Mode, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，细胞分离技术市场将成长至 600.7 亿美元，复合年增长率为 20.67%。

主要市场统计数据
基准年2024年 133.5亿美元
预计2025年 161.2亿美元
预测年份：2032年 607亿美元
复合年增长率（%） 20.67%

提供权威指导，说明不断发展的技术需求和工作流程整合的需求如何改变研究、诊断和生物製造领域的优先事项

细胞分离技术是现代生命科学工作流程的核心，推动诊断、生技药品生产和细胞疗法的进步。近年来，从传统的离心分离技术到工程化的微流体和磁选方法，分离工具的多样化和复杂化程度不断提升。这些技术如今在通量、纯度和细胞活力之间实现了持续的平衡，推动其在科学研究、临床和工业领域的差异化应用。

这一格局正受到许多压力的共同影响：对细胞和基因疗法更高品质起始材料的需求日益增长，照护现场扩展，以及生物製造领域对可扩展自动化流程的需求日益增长。随着实验室越来越重视可重复性和法规遵循性，人们越来越重视能够提供稳定分离性能，同时最大限度地减少手动操作时间和降低耗材复杂性的技术。同时，单细胞生物学和多体学工作流程的兴起，也提升了分离工具的价值，这些工具能够保持细胞完整性并支持下游分子分析。

从实验室到临床的转变不仅需要技术效能，还需要结合仪器、耗材和软体分析的整合解决方案。因此，学术界、生物技术和临床诊断领域的相关人员不仅评估分离平台的纯粹功能，还评估其生态系统契合度、工作流程总成本以及与自动化流程整合的能力。本入门框架为更深入的分析奠定了基础，包括市场变化、关税影响、细分市场细微差别、区域差异以及为该领域领导者提供的可行建议。

技术突破和不断发展的应用需求如何重新定义细胞分离性能基准、工作流程整合和商业性差异化

在技​​术创新和终端用户期望不断提升的推动下，细胞分离领域正在经历变革。结合确定性横向位移和动态分离的微流体方法，能够在某些单细胞应用中实现先前难以企及的温和高解析度分选。同时，磁激活细胞分选技术正透过正向和负向选择策略拓展其效用，从而在不影响细胞活力的情况下提高纯度。声波分离和场流分离在无标定操作和基于细胞大小的分离技术中占据着独特的优势。

虽然离心分离仍然是基础技术，但随着高通量和封闭式系统处理对生产和临床级工作流程的重要性日益提升，连续和批量也正在蓬勃发展。过滤技术正根据交叉流和死端模式进行细分，以适应不同的样品类型和污垢状况。自动化和分析软体日益被视为推动用户采用并透过可追溯的工作流程实现合规性的关键组件。

应用优先顺序的改变进一步强化了这些转变。生物製药製程需要能够无缝整合到下游和上游製程的解决方案，而临床诊断则需要快速、可重复的分离技术，并相容于癌症和感染疾病检测。从细胞生物学到基因组学再到药物研发，各种应用情境都持续要求能够维持细胞原生状态、干扰最小的方法。这些技术水准和应用层级的变革正在建立新的竞争边界，并为跨学科平台的整合铺平道路。

到 2025 年美国关税对细胞分离供应链、采购和产品设计的累积营运、采购和策略影响。

美国将在 2025 年前征收并升级关税，这使得整个细胞分离价值链，特别是资本设备、精密耗材和专用试剂供应链的考量变得更加复杂。关税的累积影响增加了进口设备和零件的到岸成本，迫使供应商和最终用户重新评估筹资策略。许多供应商透过本地化製造地、合格替代供应商和重新设计产品套件来减少对关税投入的依赖。这些调整也影响了库存政策，公司增加了缓衝库存并协商不同的运输和交货条款，以减轻前置作业时间的变化。

除了直接的成本影响外，关税还改变了竞争动态。拥有本地生产或成熟国内供应链的供应商获得了相对的采购优势，而依赖跨境零件采购的供应商则面临着吸收成本或将成本转嫁给客户的压力。对于跨国采购商而言，采购的复杂性有所增加，因为总到岸成本评估现在涵盖了关税等级、关税减免策略（例如保税仓库和关税归类申诉）以及合规的行政管理费用。

监管和合约方面的影响也十分显着。关税主导的价格调整导致供应合约重新谈判，影响了研究机构和医院的多年采购协议。面向采购的设计原则对产品开发团队日益重要，鼓励模组化和供应商多元化。展望未来，迄今为止的累积影响凸显了供应链弹性战略的必要性，该战略将近岸外包、供应商资格确认以及製造商和最终用户之间的协作规划相结合，以保持关键细胞分离工作流程的连续性。

不同的细分领域决定了整个细胞分离价值链的技术采用、产品捆绑策略和最终用户购买行为

细分洞察揭示了跨技术、产品类型、细胞类型、分离模式、应用和最终用户的差异化价值实现路径，每种路径都具有独特的商业性和技术含义。基于技术，市场涵盖声学分离、离心、场流分离、过滤、微流体激活细胞分选和微流体技术。离心进一步细分为批量和连续模式，过滤为交叉流流和死端，磁激活细胞分选细分为负选择和正选择，微流体为确定性横向位移和动态分离。这种技术细分揭示了有利于某些用例的性能权衡，例如用于高通量製造的连续离心、用于灵敏单细胞分析的微流体确定性横向位移，以及下游治疗製造需要目标细胞富集时的磁正选择。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 基于微流体晶片的稀有细胞分离平台整合用于照护现场诊断
  • 采用免疫磁性奈米粒子策略提高循环性肿瘤细胞的富集效率
  • 开发用于大规模生物处理的高通量声学细胞分选解决方案
  • 新兴的无标定介电泳装置，用于温和分离干细胞群
  • 实施人工智慧驱动的基于影像的细胞分选系统，以提高特异性和吞吐量
  • 扩展基于微流体液滴的单细胞定序样品製备工作流程
  • 临床级 CAR-T 细胞製造中自动化闭路系统细胞分离的进展

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章 细胞分离技术市场：依技术

  • 隔音效果
  • 离心
    • 批次
    • 连续的
  • 场流分馏
  • 滤
    • 交叉流
    • 死胡同
  • 磁激活细胞分选
    • 负面选择
    • 正向选择
  • 微流体
    • 确定性横向位移
    • 动态分离

第九章细胞分离技术市场：依产品

  • 耗材
    • 筛选
    • 套件
    • 试剂
  • 装置
    • 声学分离器
    • 离心机
    • 过滤系统
    • 磁选机
    • 微流体设备
  • 软体
    • 分析软体
    • 自动化软体

第 10 章：以细胞类型分類的细胞分离技术市场

  • 血球
  • 癌细胞
  • 微生物
  • 干细胞

第11章 电池分离技术市场（分离模式）

  • 批次
  • 经常使用

第十二章 细胞分离技术市场：依应用

  • 生物製药加工
    • 下游加工
    • 上游处理
  • 临床诊断
    • 癌症诊断
    • 传染病检查
  • 研究
    • 细胞生物学
    • 药物研发
    • 基因组学
  • 治疗药物
    • 细胞疗法
    • 基因治疗

第十三章 细胞分离技术市场（依最终用户）

  • 学术机构
  • 生技公司
  • 合约研究组织
  • 医院
  • 实验室

第十四章细胞分离技术市场：按地区

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 细胞分离技术市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 细胞分离技术市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Miltenyi Biotec GmbH
    • STEMCELL Technologies Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Roche Holding AG
    • Sartorius AG
    • GE HealthCare Technologies Inc.
Product Code: MRR-433AB1DC28D0

The Cell Separation Technologies Market is projected to grow by USD 60.07 billion at a CAGR of 20.67% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 13.35 billion
Estimated Year [2025] USD 16.12 billion
Forecast Year [2032] USD 60.07 billion
CAGR (%) 20.67%

An authoritative orientation to how evolving technical demands and workflow integration imperatives are reshaping priorities across research, diagnostics and biomanufacturing

Cell separation technologies are central to modern life sciences workflows, underpinning advances in diagnostics, biologics manufacturing, and cell-based therapies. Recent years have seen an acceleration in tool diversity and sophistication, with methods that range from classical centrifugation to engineered microfluidic and magnetic selection approaches. These techniques now operate across a continuum of throughput, purity and viability trade-offs, driving differentiated adoption across research, clinical and industrial settings.

The landscape is shaped by converging pressures: growing demand for higher-quality starting material for cell and gene therapies, the expansion of point-of-care diagnostics, and the need for scalable, automated processes in biomanufacturing. As laboratories prioritize reproducibility and regulatory compliance, there is increasing emphasis on technologies that deliver consistent separation performance while minimizing hands-on time and consumable complexity. In parallel, the rise of single-cell biology and multi-omic workflows amplifies the value of separation tools that preserve cell integrity and enable downstream molecular interrogation.

Transitioning from bench to bedside requires not only technical performance but also integrated solutions that combine instruments, consumables and software analytics. Stakeholders across academia, biotech and clinical diagnostics are therefore evaluating separation platforms not solely on raw capability, but on ecosystem fit, total workflow cost, and the ability to integrate into automated pipelines. This introductory framing sets the stage for deeper analysis of market shifts, tariff impacts, segmentation nuances, regional differentials and actionable recommendations for leaders in the field.

How converging technological breakthroughs and evolving application demands are redefining performance benchmarks, workflow integration and commercial differentiation in cell separation

The cell separation domain is undergoing transformative shifts driven by both technological innovation and evolving end-user expectations. Microfluidic approaches, with deterministic lateral displacement and hydrodynamic separation variants, are enabling gentle, high-resolution sorting at scales previously unattainable for certain single-cell applications. Concurrently, magnetic activated cell sorting has broadened its utility by enabling both positive and negative selection strategies that improve purity without compromising viability. Acoustic separation and field flow fractionation are occupying niche roles where label-free manipulation or size-based fractionation provide distinct advantages.

Centrifugation remains foundational, but continuous formats are gaining momentum alongside batch configurations as throughput and closed-system processing become more critical for manufacturing and clinical-grade workflows. Filtration technologies are differentiating along cross-flow and dead-end modalities to accommodate diverse sample types and fouling profiles. Instrument sophistication is matched by a growing software imperative: automation and analysis software are increasingly considered integral components that drive user adoption and enable compliance through traceable workflows.

These shifts are reinforced by changing application priorities. Biopharmaceutical processing demands solutions that integrate seamlessly into downstream and upstream processing pipelines, while clinical diagnostics require rapid, reproducible separation compatible with cancer and infectious disease assays. Research use cases, ranging from cell biology to genomics and drug discovery, continue to push for minimally perturbative methods that preserve native cell states. Taken together, the technological and application-level transformations are forging new competitive boundaries and opening pathways for cross-disciplinary platform convergence.

The cumulative operational, procurement and strategic consequences of United States tariff actions through 2025 on supply chains, sourcing choices and product design for cell separation

The imposition and escalation of tariff measures in the United States through 2025 have compounded supply chain considerations across the cell separation value chain, especially for capital equipment, precision consumables and specialized reagents. Cumulative tariff effects have raised landed costs for imported instruments and components, prompting suppliers and end users to reassess sourcing strategies. Many vendors have responded by regionalising manufacturing footprints, qualifying alternative suppliers, or redesigning product kits to reduce reliance on tarifflable inputs. These adjustments have also influenced inventory policies, with organisations maintaining higher buffer stocks or negotiating different freight and delivery terms to mitigate lead time variability.

In addition to direct cost impacts, tariffs have altered competitive dynamics. Vendors with localised production or established domestic supply chains have gained relative procurement advantages, while those dependent on cross-border componentry face pressure to absorb costs or pass them on to customers. For multinational buyers, procurement complexity has increased as total landed cost assessments now incorporate tariff brackets, duty mitigation strategies such as bonded warehouses or tariff classification appeals, and the administrative overhead of compliance.

Regulatory and contractual implications are also consequential. Tariff-driven price adjustments have led to renegotiation of supply agreements and have affected multi-year procurement contracts in research institutions and hospitals. For product development teams, design-for-sourcing principles have become more salient, encouraging modularity and supplier diversification. Looking forward, the cumulative impact to date underscores the need for supply chain resilience strategies that blend nearshoring, supplier qualification, and collaborative planning between manufacturers and end users to sustain continuity of critical cell separation workflows.

Clear segmentation distinctions that dictate technology adoption, product bundling strategies and end-user procurement behaviours across the cell separation value chain

Segmentation insights reveal differentiated routes to value across technology, product, cell type, separation mode, application and end-user dimensions that each carry distinct commercial and technical implications. Based on Technology, the market spans acoustic separation, centrifugation, field flow fractionation, filtration, magnetic activated cell sorting, and microfluidics, with centrifugation further delineated into batch and continuous modes, filtration into cross-flow and dead-end, magnetic activated cell sorting into negative selection and positive selection, and microfluidics into deterministic lateral displacement and hydrodynamic separation. This technological granularity highlights where performance trade-offs favor specific use cases: continuous centrifugation for high-throughput manufacturing, microfluidic deterministic lateral displacement for delicate single-cell assays, and magnetic positive selection where targeted cell enrichment is required for downstream therapeutic manufacturing.

Based on Product, the landscape includes consumables, instruments, and software, with consumables further segmented into filters, kits, and reagents, instruments into acoustic separators, centrifuges, filtration systems, magnetic separators, and microfluidic devices, and software into analysis and automation offerings. This product segmentation underscores the emergence of bundled solutions where instrument manufacturers increasingly offer certified consumables and analytics to lock in workflow consistency and create recurring revenue models.

Based on Cell Type, differentiation by blood cells, cancer cells, microorganisms, and stem cells drives application-specific requirements for purity, viability and throughput, with stem cell and cancer cell separations commanding stringent process controls. Based on Separation Mode, the dichotomy between batch and continuous processing maps directly onto use-case scale: research and diagnostic labs often prefer batch modalities for flexibility, whereas industrial bioprocessing trends toward continuous modes for efficiency. Based on Application, categories include biopharmaceutical processing-split across downstream and upstream processing-clinical diagnostics covering cancer diagnosis and infectious disease testing, research spanning cell biology, drug discovery and genomics, and therapeutics addressing cell therapy and gene therapy, each imposing unique validation and traceability demands. Based on End User, academic institutes, biotechnology companies, contract research organisations, hospitals, and research laboratories represent distinct buying behaviours, procurement cycles and regulatory exposures, shaping how vendors package technical performance with service, training and compliance support.

How distinct regional levers in the Americas, Europe Middle East & Africa and Asia-Pacific shape adoption priorities, procurement patterns and supplier competitive advantage

Regional dynamics exert a material influence on technology adoption, regulatory expectation, and supply chain strategy across three principal geographies. In the Americas, demand is anchored by strong clinical trial activity, an advanced biopharmaceutical manufacturing base, and significant investment in cell and gene therapies, driving preference for scalable continuous processing solutions and validated, high-throughput platforms. Suppliers with localised production and service networks are often advantaged in procurement cycles that prioritise rapid deployment and aftermarket support.

In Europe, Middle East & Africa, regulatory harmonisation trends and a dense network of academic research institutions shape adoption patterns. Clinical diagnostics and translational research initiatives emphasize reproducibility and compliance, while cost-containment pressures in certain healthcare markets influence procurement choices toward platforms that demonstrate total workflow efficiency and consumable cost-effectiveness. In this region, collaborative research consortia and public-private partnerships frequently accelerate uptake of cutting-edge separation methodologies.

In Asia-Pacific, rapid expansion of biotech ecosystems, significant contract manufacturing growth, and substantial investments in diagnostics capacity have created a diverse demand profile. Market entrants and incumbent vendors that can offer modular, low-footprint solutions and provide local training and service infrastructure tend to capture a larger share of institutional adoption. Across all regions, regional supply chain resilience, local regulatory landscapes and the availability of skilled technical support remain key determinants of platform selection and long-term partnership viability.

Competitive imperatives and strategic moves by technology vendors that create platform stickiness through integration of instruments, consumables, software and services

Company-level dynamics are driven by strategic choices around vertical integration, recurring consumable models, software-enabled differentiation and geographic footprint. Leading instrument manufacturers that combine robust hardware portfolios with certified consumables and intuitive automation software are creating stickiness that extends beyond initial capital sales. Such companies prioritise long-term service agreements, training programmes, and consumable contracts to stabilise revenue streams and deepen customer relationships.

Smaller, specialised technology providers often focus on niche differentiation-delivering high-resolution separation modalities or platform interoperability that enables integration into broader workflows. These firms can be agile in adopting design-for-manufacturing changes and in forging partnerships with larger distributors to scale reach. Contract research organisations and contract manufacturers are also evolving from being just end users to strategic collaborators, co-developing tailored separation workflows and co-investing in process optimisation to meet clinical and commercial manufacturing needs.

Across the competitive set, those firms that invest in analytics-driven software, robust validation packages, and comprehensive training resources tend to win in regulated environments. Strategic M&A activity continues to be a lever for expanding technological breadth and geographic service coverage, while partnerships with reagent and kit suppliers help to secure an integrated offering that addresses the full workflow from sample input to downstream analysis or therapeutic-grade output.

Practical strategic actions leaders can deploy now to secure supply resilience, commercial differentiation and faster adoption of cell separation platforms

Leaders should prioritise three actionable initiatives to translate insight into commercial and operational advantage. First, invest in modular product architectures and certified consumable ecosystems that reduce customer onboarding friction and create recurring revenue streams; coupling instruments with validated kits and analytics simplifies regulatory submissions for customers and strengthens vendor positioning. Second, develop flexible sourcing and regional manufacturing strategies that mitigate tariff exposure and supply disruption; nearshoring critical components, qualifying secondary suppliers, and integrating tariff-aware pricing into contract negotiations can protect margins and customer commitments.

Third, accelerate software-enabled differentiation by embedding automation and analytics into separation platforms to facilitate reproducibility, traceability and remote monitoring; software can be a decisive factor for adoption in clinical and manufacturing settings where process control and documentation are non-negotiable. Complementing product development with strong training, service networks and co-development partnerships with academic and industrial labs will further reduce time-to-deployment and enhance customer retention.

Operationally, adopt design-for-sourcing and lifecycle management practices that reduce dependence on single suppliers or tariff-sensitive components. Commercially, prioritise flexible contracting and pilot programmes that lower adoption barriers for new customers. Collectively, these actions enhance resilience, accelerate adoption, and create defensible differentiation in a market where technical performance must be matched by service and supply chain reliability.

A rigorous multi-method research approach combining primary stakeholder interviews, secondary evidence and cross-segmentation analysis to produce actionable, validated insights

This research synthesis is grounded in a multi-method approach combining primary intelligence, secondary literature review and structured analytical frameworks to ensure robustness and contextual relevance. Primary data collection included in-depth interviews with technical leaders across academic laboratories, biopharmaceutical manufacturers, clinical diagnostics groups and contract research organisations, enabling nuanced understanding of real-world workflows, purchasing criteria and operational pain points. Secondary sources were interrogated to validate technology descriptions, regulatory developments, and public company disclosures relevant to production and distribution practices.

Analytical techniques employed include cross-segmentation mapping to align technologies with application requirements, supplier capability matrices to assess product and service differentiation, and scenario analysis to evaluate tariff and supply chain contingencies. Triangulation of data points ensured consistency between stakeholder perspectives and documented operational behaviors, while iterative peer review among subject-matter experts refined interpretations and prioritized insights. The methodology also incorporated careful attention to regional regulatory frameworks and procurement models to render recommendations that are both actionable and context-aware.

Limitations were acknowledged and addressed through targeted follow-ups and sensitivity checks, particularly where nascent technologies exhibit rapid iteration. The result is a defensible, practitioner-oriented synthesis intended to support strategic planning, vendor selection, and operational optimisation in cell separation workflows.

A concise synthesis of how technology integration, supply resilience and targeted segmentation will determine winners in the evolving cell separation ecosystem

In conclusion, the cell separation landscape is at an inflection point where technological variety, application-specific demands, and supply chain realities converge to reshape vendor strategy and end-user procurement behaviour. The interplay between instrument capability, consumable ecosystems and software-driven automation will determine long-term adoption patterns. Organisations that prioritise integrated solutions, supply chain resilience and software-enabled reproducibility are best positioned to capture the opportunities that arise from expanding therapeutic and diagnostic applications.

Tariff dynamics and regional supply chain divergences have underscored the importance of sourcing flexibility and regional service infrastructure. At the same time, segmentation by technology, product, cell type, application and end user reveals clear pathways for vendors to target high-value use cases while balancing the need for scale and regulatory compliance. Ultimately, the most successful players will be those that can combine technical excellence with pragmatic commercial models, enabling customers to translate separation performance into reliable downstream outcomes for research, clinical diagnostics and therapeutic manufacturing.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of microfluidic chip-based rare cell isolation platforms for point-of-care diagnostics
  • 5.2. Adoption of immunomagnetic nanoparticle strategies to enhance circulating tumor cell enrichment efficiency
  • 5.3. Development of high-throughput acoustic wave cell sorting solutions for large-scale bioprocessing
  • 5.4. Emergence of label-free dielectrophoresis-based devices for gentle separation of stem cell populations
  • 5.5. Implementation of AI-driven image-based cell sorting systems to improve specificity and throughput
  • 5.6. Expansion of microfluidic droplet-based single-cell sequencing sample preparation workflows
  • 5.7. Advances in automated closed-system cell isolation for clinical grade CAR-T cell manufacturing

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cell Separation Technologies Market, by Technology

  • 8.1. Acoustic Separation
  • 8.2. Centrifugation
    • 8.2.1. Batch
    • 8.2.2. Continuous
  • 8.3. Field Flow Fractionation
  • 8.4. Filtration
    • 8.4.1. Cross Flow
    • 8.4.2. Dead End
  • 8.5. Magnetic Activated Cell Sorting
    • 8.5.1. Negative Selection
    • 8.5.2. Positive Selection
  • 8.6. Microfluidics
    • 8.6.1. Deterministic Lateral Displacement
    • 8.6.2. Hydrodynamic Separation

9. Cell Separation Technologies Market, by Product

  • 9.1. Consumables
    • 9.1.1. Filters
    • 9.1.2. Kits
    • 9.1.3. Reagents
  • 9.2. Instruments
    • 9.2.1. Acoustic Separators
    • 9.2.2. Centrifuges
    • 9.2.3. Filtration Systems
    • 9.2.4. Magnetic Separators
    • 9.2.5. Microfluidic Devices
  • 9.3. Software
    • 9.3.1. Analysis Software
    • 9.3.2. Automation Software

10. Cell Separation Technologies Market, by Cell Type

  • 10.1. Blood Cells
  • 10.2. Cancer Cells
  • 10.3. Microorganisms
  • 10.4. Stem Cells

11. Cell Separation Technologies Market, by Separation Mode

  • 11.1. Batch
  • 11.2. Continuous

12. Cell Separation Technologies Market, by Application

  • 12.1. Biopharmaceutical Processing
    • 12.1.1. Downstream Processing
    • 12.1.2. Upstream Processing
  • 12.2. Clinical Diagnostics
    • 12.2.1. Cancer Diagnosis
    • 12.2.2. Infectious Disease Testing
  • 12.3. Research
    • 12.3.1. Cell Biology
    • 12.3.2. Drug Discovery
    • 12.3.3. Genomics
  • 12.4. Therapeutics
    • 12.4.1. Cell Therapy
    • 12.4.2. Gene Therapy

13. Cell Separation Technologies Market, by End User

  • 13.1. Academic Institutes
  • 13.2. Biotechnology Companies
  • 13.3. Contract Research Organizations
  • 13.4. Hospitals
  • 13.5. Research Laboratories

14. Cell Separation Technologies Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Cell Separation Technologies Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Cell Separation Technologies Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Thermo Fisher Scientific Inc.
    • 17.3.2. Danaher Corporation
    • 17.3.3. Merck KGaA
    • 17.3.4. Miltenyi Biotec GmbH
    • 17.3.5. STEMCELL Technologies Inc.
    • 17.3.6. Becton, Dickinson and Company
    • 17.3.7. Bio-Rad Laboratories, Inc.
    • 17.3.8. Roche Holding AG
    • 17.3.9. Sartorius AG
    • 17.3.10. GE HealthCare Technologies Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. CELL SEPARATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. CELL SEPARATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CELL SEPARATION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ACOUSTIC SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ACOUSTIC SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ACOUSTIC SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ACOUSTIC SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ACOUSTIC SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ACOUSTIC SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FIELD FLOW FRACTIONATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FIELD FLOW FRACTIONATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FIELD FLOW FRACTIONATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FIELD FLOW FRACTIONATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FIELD FLOW FRACTIONATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FIELD FLOW FRACTIONATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CROSS FLOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CROSS FLOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CROSS FLOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CROSS FLOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CROSS FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CROSS FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DEAD END, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DEAD END, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DEAD END, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DEAD END, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DEAD END, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DEAD END, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC ACTIVATED CELL SORTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY NEGATIVE SELECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY NEGATIVE SELECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY NEGATIVE SELECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY NEGATIVE SELECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY NEGATIVE SELECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY NEGATIVE SELECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY POSITIVE SELECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY POSITIVE SELECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY POSITIVE SELECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY POSITIVE SELECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY POSITIVE SELECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY POSITIVE SELECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DETERMINISTIC LATERAL DISPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DETERMINISTIC LATERAL DISPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DETERMINISTIC LATERAL DISPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DETERMINISTIC LATERAL DISPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DETERMINISTIC LATERAL DISPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DETERMINISTIC LATERAL DISPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY HYDRODYNAMIC SEPARATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY HYDRODYNAMIC SEPARATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY HYDRODYNAMIC SEPARATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY HYDRODYNAMIC SEPARATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY HYDRODYNAMIC SEPARATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY HYDRODYNAMIC SEPARATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ACOUSTIC SEPARATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ACOUSTIC SEPARATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ACOUSTIC SEPARATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ACOUSTIC SEPARATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ACOUSTIC SEPARATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ACOUSTIC SEPARATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY FILTRATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC SEPARATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC SEPARATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC SEPARATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC SEPARATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC SEPARATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MAGNETIC SEPARATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROFLUIDIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ANALYSIS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ANALYSIS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ANALYSIS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY ANALYSIS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY AUTOMATION SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY AUTOMATION SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY AUTOMATION SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY AUTOMATION SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY AUTOMATION SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY AUTOMATION SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BLOOD CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BLOOD CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BLOOD CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BLOOD CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BLOOD CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BLOOD CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CANCER CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CANCER CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CANCER CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CANCER CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CANCER CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CANCER CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROORGANISMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROORGANISMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROORGANISMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROORGANISMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROORGANISMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY MICROORGANISMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY STEM CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY SEPARATION MODE, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BATCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BATCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BATCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BATCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BATCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BATCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONTINUOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CONTINUOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DOWNSTREAM PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DOWNSTREAM PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY UPSTREAM PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY UPSTREAM PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CANCER DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CANCER DIAGNOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CANCER DIAGNOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CANCER DIAGNOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CANCER DIAGNOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CANCER DIAGNOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL BIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL BIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL BIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL BIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL BIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY CELL BIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET SIZE, BY GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL CELL SEPARATION TECHNOLOGIES MARKET S